Samar Ojaimi

1.3k total citations
35 papers, 640 citations indexed

About

Samar Ojaimi is a scholar working on Immunology, Epidemiology and Infectious Diseases. According to data from OpenAlex, Samar Ojaimi has authored 35 papers receiving a total of 640 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Immunology, 10 papers in Epidemiology and 7 papers in Infectious Diseases. Recurrent topics in Samar Ojaimi's work include Immunodeficiency and Autoimmune Disorders (9 papers), Cell death mechanisms and regulation (4 papers) and Drug-Induced Adverse Reactions (3 papers). Samar Ojaimi is often cited by papers focused on Immunodeficiency and Autoimmune Disorders (9 papers), Cell death mechanisms and regulation (4 papers) and Drug-Induced Adverse Reactions (3 papers). Samar Ojaimi collaborates with scholars based in Australia, Belgium and South Korea. Samar Ojaimi's co-authors include Michael D. Stutz, Marc Pellegrini, Simon Preston, Cody C. Allison, John Silke, Ian Woolley, Gregor Ebert, Vijaya Sundararajan, Narelle Skinner and Kumar Visvanathan and has published in prestigious journals such as Proceedings of the National Academy of Sciences, SHILAP Revista de lepidopterología and Immunity.

In The Last Decade

Samar Ojaimi

32 papers receiving 626 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Samar Ojaimi Australia 13 212 175 162 145 85 35 640
Jann Lübbe Switzerland 17 181 0.9× 78 0.4× 139 0.9× 125 0.9× 68 0.8× 32 1.1k
Nuanjun Wichukchinda Thailand 19 248 1.2× 271 1.5× 126 0.8× 362 2.5× 266 3.1× 45 943
John G. Chosay United States 12 125 0.6× 285 1.6× 300 1.9× 279 1.9× 63 0.7× 16 934
Dong Hee Whang South Korea 17 187 0.9× 233 1.3× 87 0.5× 120 0.8× 23 0.3× 56 876
Mélanie R. Tardif Canada 17 262 1.2× 678 3.9× 500 3.1× 159 1.1× 78 0.9× 28 1.3k
Xiaojun Li China 14 144 0.7× 230 1.3× 224 1.4× 86 0.6× 12 0.1× 43 734
Manish Patel United States 15 72 0.3× 263 1.5× 64 0.4× 175 1.2× 46 0.5× 42 816
Jingguo Zhou China 17 133 0.6× 135 0.8× 392 2.4× 49 0.3× 21 0.2× 51 822
Souphalone Luangsay France 12 494 2.3× 266 1.5× 151 0.9× 66 0.5× 44 0.5× 17 835
Imran Ahmad United States 15 196 0.9× 96 0.5× 345 2.1× 339 2.3× 80 0.9× 21 1.1k

Countries citing papers authored by Samar Ojaimi

Since Specialization
Citations

This map shows the geographic impact of Samar Ojaimi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Samar Ojaimi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Samar Ojaimi more than expected).

Fields of papers citing papers by Samar Ojaimi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Samar Ojaimi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Samar Ojaimi. The network helps show where Samar Ojaimi may publish in the future.

Co-authorship network of co-authors of Samar Ojaimi

This figure shows the co-authorship network connecting the top 25 collaborators of Samar Ojaimi. A scholar is included among the top collaborators of Samar Ojaimi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Samar Ojaimi. Samar Ojaimi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ojaimi, Samar, et al.. (2025). Transient Increased Risk of Shingles Post–Shingrix Vaccination: Self-Controlled Case-Series Analysis. Clinical Infectious Diseases. 81(5). e446–e453. 1 indexed citations
2.
Phuong, Linny Kimly, Tamrat Befekadu Abebe, Zanfina Ademi, et al.. (2024). Epidemiology of childhood invasive pneumococcal disease in Australia: a prospective cohort study. Archives of Disease in Childhood. 110(1). 52–58. 1 indexed citations
3.
Sée, J., Jessica Fairley, Ai Li Yeo, Samar Ojaimi, & Eric F. Morand. (2024). Anti‐MDA5 positivity: describing the frequency and spectrum of clinically evident MDA5 disease. Internal Medicine Journal. 54(12). 2061–2066. 1 indexed citations
4.
Loh, Mignon L., et al.. (2024). Phenotype of patients with late diagnosis of 22q11 deletion: a review and retrospective study. Internal Medicine Journal. 54(12). 2015–2026.
5.
Kong, Kok Ooi, Sara Barnes, G. Jenkin, et al.. (2023). Disseminated tuberculosis, CMV viraemia & haemophagocytic-lymphohistiocystosis syndrome in an adult patient with anti- IFNγ autoantibodies – case report and brief review. SHILAP Revista de lepidopterología. 4. 55–59. 2 indexed citations
6.
Edwards, Emily S.J., Samar Ojaimi, Go Hun Seo, et al.. (2023). Combined immunodeficiency and impaired PI3K signaling in a patient with biallelic LCP2 variants. Journal of Allergy and Clinical Immunology. 152(3). 807–813.e7. 6 indexed citations
7.
Jones, Penelope, et al.. (2022). Congenital asplenia study: clinical and laboratory characterisation of adults with congenital asplenia. Annals of Hematology. 101(7). 1421–1434.
8.
9.
Stutz, Michael D., Cody C. Allison, Samar Ojaimi, et al.. (2021). Macrophage and neutrophil death programs differentially confer resistance to tuberculosis. Immunity. 54(8). 1758–1771.e7. 66 indexed citations
10.
Hartley, Gemma E., Emily S.J. Edwards, Julian J. Bosco, et al.. (2020). Influenza‐specific IgG1+ memory B‐cell numbers increase upon booster vaccination in healthy adults but not in patients with predominantly antibody deficiency. Clinical & Translational Immunology. 9(10). e1199–e1199. 12 indexed citations
11.
Yeo, Ai Li, Suong Le, Jason J. Ong, et al.. (2020). Utility of repeated antinuclear antibody tests: a retrospective database study. The Lancet Rheumatology. 2(7). e412–e417. 11 indexed citations
12.
Edwards, Emily S.J., Julian J. Bosco, Samar Ojaimi, Robyn E. O’Hehir, & Menno C. van Zelm. (2020). Beyond monogenetic rare variants: tackling the low rate of genetic diagnoses in predominantly antibody deficiency. Cellular and Molecular Immunology. 18(3). 588–603. 27 indexed citations
13.
Trevenen, Michelle, William Smith, Constance H. Katelaris, et al.. (2019). Multicenter Australian Study to Determine Criteria for Low- and High-Risk Penicillin Testing in Outpatients. The Journal of Allergy and Clinical Immunology In Practice. 8(2). 681–689.e3. 48 indexed citations
14.
Stutz, Michael D., Samar Ojaimi, Gregor Ebert, & Marc Pellegrini. (2018). Is Receptor-Interacting Protein Kinase 3 a Viable Therapeutic Target for Mycobacterium tuberculosis Infection?. Frontiers in Immunology. 9. 1178–1178. 12 indexed citations
15.
Slade, C, Samar Ojaimi, Sara Barnes, et al.. (2018). Pitfalls of immunotherapy: lessons from a patient with CTLA-4 haploinsufficiency. Allergy Asthma and Clinical Immunology. 14(1). 65–65. 7 indexed citations
16.
Stutz, Michael D., Samar Ojaimi, Cody C. Allison, et al.. (2017). Necroptotic signaling is primed in Mycobacterium tuberculosis-infected macrophages, but its pathophysiological consequence in disease is restricted. Cell Death and Differentiation. 25(5). 951–965. 70 indexed citations
17.
Ebert, Gregor, Simon Preston, Cody C. Allison, et al.. (2015). Cellular inhibitor of apoptosis proteins prevent clearance of hepatitis B virus. Proceedings of the National Academy of Sciences. 112(18). 5797–5802. 75 indexed citations
18.
Ojaimi, Samar, et al.. (2013). Vitamin d deficiency impacts on expression of toll-like receptor-2 and cytokine profile: a pilot study. Journal of Translational Medicine. 11(1). 176–176. 69 indexed citations
19.
Ojaimi, Samar, Paul R. Harnett, & David A. Fulcher. (2013). Successful carboplatin desensitization by using omalizumab and paradoxical diminution of total IgE levels. The Journal of Allergy and Clinical Immunology In Practice. 2(1). 105–106. 21 indexed citations
20.
Ojaimi, Samar, Jim Buttery, & Tony M. Korman. (2009). Quadrivalent Human Papillomavirus recombinant vaccine associated lipoatrophy. Vaccine. 27(36). 4876–4878. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jann Lübbe Breakdown of academic impact, for papers by Nuanjun Wichukchinda Breakdown of academic impact, for papers by John G. Chosay Breakdown of academic impact, for papers by Dong Hee Whang Breakdown of academic impact, for papers by Mélanie R. Tardif Breakdown of academic impact, for papers by Xiaojun Li Breakdown of academic impact, for papers by Manish Patel Breakdown of academic impact, for papers by Jingguo Zhou Breakdown of academic impact, for papers by Souphalone Luangsay Breakdown of academic impact, for papers by Imran Ahmad
Rankless by CCL
2026